IBDEI0RH ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12892,1,3,0)
 ;;=3^Steatocystoma Multiplex
 ;;^UTILITY(U,$J,358.3,12892,1,4,0)
 ;;=4^L72.2
 ;;^UTILITY(U,$J,358.3,12892,2)
 ;;=^5009280
 ;;^UTILITY(U,$J,358.3,12893,0)
 ;;=L72.8^^53^582^151
 ;;^UTILITY(U,$J,358.3,12893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12893,1,3,0)
 ;;=3^Follicular Cysts of Skin/Subcutaneous Tissue NEC
 ;;^UTILITY(U,$J,358.3,12893,1,4,0)
 ;;=4^L72.8
 ;;^UTILITY(U,$J,358.3,12893,2)
 ;;=^5009282
 ;;^UTILITY(U,$J,358.3,12894,0)
 ;;=L72.9^^53^582^152
 ;;^UTILITY(U,$J,358.3,12894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12894,1,3,0)
 ;;=3^Follicular Cysts of Skin/Subcutaneous Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,12894,1,4,0)
 ;;=4^L72.9
 ;;^UTILITY(U,$J,358.3,12894,2)
 ;;=^5009283
 ;;^UTILITY(U,$J,358.3,12895,0)
 ;;=L73.0^^53^582^3
 ;;^UTILITY(U,$J,358.3,12895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12895,1,3,0)
 ;;=3^Acne Keloid
 ;;^UTILITY(U,$J,358.3,12895,1,4,0)
 ;;=4^L73.0
 ;;^UTILITY(U,$J,358.3,12895,2)
 ;;=^2149
 ;;^UTILITY(U,$J,358.3,12896,0)
 ;;=L73.2^^53^582^159
 ;;^UTILITY(U,$J,358.3,12896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12896,1,3,0)
 ;;=3^Hidradenitis Suppurativa
 ;;^UTILITY(U,$J,358.3,12896,1,4,0)
 ;;=4^L73.2
 ;;^UTILITY(U,$J,358.3,12896,2)
 ;;=^278979
 ;;^UTILITY(U,$J,358.3,12897,0)
 ;;=L73.9^^53^582^153
 ;;^UTILITY(U,$J,358.3,12897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12897,1,3,0)
 ;;=3^Follicular Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,12897,1,4,0)
 ;;=4^L73.9
 ;;^UTILITY(U,$J,358.3,12897,2)
 ;;=^5009286
 ;;^UTILITY(U,$J,358.3,12898,0)
 ;;=L82.0^^53^582^160
 ;;^UTILITY(U,$J,358.3,12898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12898,1,3,0)
 ;;=3^Inflamed Seborrheic Keratosis
 ;;^UTILITY(U,$J,358.3,12898,1,4,0)
 ;;=4^L82.0
 ;;^UTILITY(U,$J,358.3,12898,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,12899,0)
 ;;=L82.1^^53^582^264
 ;;^UTILITY(U,$J,358.3,12899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12899,1,3,0)
 ;;=3^Seborrheic Keratosis NEC
 ;;^UTILITY(U,$J,358.3,12899,1,4,0)
 ;;=4^L82.1
 ;;^UTILITY(U,$J,358.3,12899,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,12900,0)
 ;;=L84.^^53^582^116
 ;;^UTILITY(U,$J,358.3,12900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12900,1,3,0)
 ;;=3^Corns and Callosities
 ;;^UTILITY(U,$J,358.3,12900,1,4,0)
 ;;=4^L84.
 ;;^UTILITY(U,$J,358.3,12900,2)
 ;;=^271920
 ;;^UTILITY(U,$J,358.3,12901,0)
 ;;=L85.0^^53^582^8
 ;;^UTILITY(U,$J,358.3,12901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12901,1,3,0)
 ;;=3^Acquired Ichthyosis
 ;;^UTILITY(U,$J,358.3,12901,1,4,0)
 ;;=4^L85.0
 ;;^UTILITY(U,$J,358.3,12901,2)
 ;;=^5009320
 ;;^UTILITY(U,$J,358.3,12902,0)
 ;;=L85.1^^53^582^10
 ;;^UTILITY(U,$J,358.3,12902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12902,1,3,0)
 ;;=3^Acquired Keratosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,12902,1,4,0)
 ;;=4^L85.1
 ;;^UTILITY(U,$J,358.3,12902,2)
 ;;=^5009321
 ;;^UTILITY(U,$J,358.3,12903,0)
 ;;=L85.2^^53^582^166
 ;;^UTILITY(U,$J,358.3,12903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12903,1,3,0)
 ;;=3^Keratosis Punctata
 ;;^UTILITY(U,$J,358.3,12903,1,4,0)
 ;;=4^L85.2
 ;;^UTILITY(U,$J,358.3,12903,2)
 ;;=^5009322
 ;;^UTILITY(U,$J,358.3,12904,0)
 ;;=L85.3^^53^582^289
 ;;^UTILITY(U,$J,358.3,12904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12904,1,3,0)
 ;;=3^Xerosis Cutis
 ;;^UTILITY(U,$J,358.3,12904,1,4,0)
 ;;=4^L85.3
 ;;^UTILITY(U,$J,358.3,12904,2)
 ;;=^5009323
 ;;^UTILITY(U,$J,358.3,12905,0)
 ;;=L86.^^53^582^164
 ;;^UTILITY(U,$J,358.3,12905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12905,1,3,0)
 ;;=3^Keratoderma in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,12905,1,4,0)
 ;;=4^L86.
